Astrocytes gained attention as important players in neurological disease, including a number of leukodystrophies. Several studies explored the generation of induced pluripotent stem cell-derived astrocytes for drug screening and regenerative studies. Developing robust models of patient induced pluripotent stem cells is challenged by high variability due to diverse genetic backgrounds and long-term culture procedures. While human models are of special interest, mouse-based models have the advantage that for them these issues are less pronounced. Here we present astrocyte differentiation protocols for both human and mouse induced pluripotent stem cells to specifically induce grey and white matter astrocytes. Both subtypes expressed astrocyte-associated markers, had typical astrocyte morphologies, and gave a reactive response to stress. Importantly, the grey and white matter-like astrocytes differed in size, complexity of processes, and expression profile, conform primary grey and white matter astrocytes. The newly presented mouse and human stem cell-based models for the leukodystrophy Vanishing White Matter replicated earlier findings, such as increased proliferation, decreased OPC maturation and modulation by hyaluronidase. We studied intrinsic astrocyte subtype vulnerability in Vanishing White Matter in both human and mouse
Introduction
The importance of astrocytes in neurological disease is recognized increasingly, such as in Rett syndrome (Williams et al., 2014) and amyotrophic lateral sclerosis (Yamanaka and Komine, 2018) , although their exact function(s) in health and disease remain unclear. Both mouse models and human induced pluripotent stem cell (hiPSC)-based cultures proved the central role of astrocytes in neuronal dysfunction (Oksanen et al., 2017; Rakela et al., 2018; Russo et al., 2018) . Especially mouse transgenic studies advanced our knowledge on gene function and how single gene disruption affects cell development in neuronal and glial cell lineages (Leung and Jia, 2016) . However, monogenic changes in mice do not always replicate the cellular or clinical phenotypes in human patients, which might be caused by phylogenetic differences between humans and rodents. The discovery of hiPSCs (Takahashi et al., 2007) greatly enhanced the possibility to study patient-and disease-specific cells. HiPSC-derived astrocytes successfully modeled neurodegenerative and neurodevelopmental disorders (Gupta et al., 2013; Chandrasekaran et al., 2016) . However, hiPSC technology is challenged by high variability due to low standardization of in vitro protocols and due to induction of genetic changes during reprogramming and long term culturing (Falk et al., 2016) . Furthermore, hiPSC-based models are labor-intensive, which often results in small sample sizes. As mouse pluripotent stem cell differentiations are more robust due to faster and more standardized protocols and the use of genetically similar inbred strains, mouse-based cultures are very useful. Thereby both human and mouse models present with advantages and disadvantages, and can therefore be complementary in studies of astrocyte functions in health and neurological disease.
Several studies indicate that astrocytes consist of functionally and morphologically heterogeneous populations of cells, that develop at different times and different locations in the central nervous system (CNS) under the influence of different intrinsic and environmental factors (Bayraktar et al., 2014; Molofsky and Deneen, 2015) . Neurological disorders show defects in specific astrocyte subtypes (Martinian et al., 2009; Middeldorp et al., 2009; Diaz-Amarilla et al., 2011) . This is especially clear in Vanishing White Matter (VWM), one of the more prevalent leukodystrophies, which is caused by mutations in the EIF2B1-5 genes and for which no treatment is available (Van der Knaap, 2016) . Previous studies showed that white matter astrocytes are selectively affected in VWM, while grey matter astrocytes are spared (Bugiani et al., 2011; Bugiani et al., 2013; Dooves et al., 2016; Leferink et al., 2017) . These findings indicate that it is essential to generate iPSC models for disease-related astrocyte subtypes. Even though astrocyte differentiation protocols are available for both mouse (Kuegler et al., 2012; Kleiderman et al., 2016) and human stem cells (Krencik and Zhang, 2011; Emdad et al., 2012; Shaltouki et al., 2013; Tcw et al., 2017; Nadadhur et al., 2018) , these do not generate specific astrocyte subtypes. Consequently, no disease modeling studies have been performed comparing different astrocyte subtypes. We are therefore in need of iPSC differentiation protocols to generate specific astrocyte subtypes, such as grey and white matter-specific astrocytes, to mimic disease-specific phenotypes.
In this study, we created in vitro models for VWM using hiPSCs and miPSCs ( Fig. 1) .
We thereby present new protocols to generate iPSC-derived astrocyte subtypes, using signaling molecules stimulating grey (using fetal bovine serum; FBS) and white (incl. ciliary neurotrophic factor; CNTF) matter. The cells were characterized for astrocyte-associated morphologies, marker expression, reactivity, and were analyzed for transcriptomics using RNA sequencing (RNAseq). Interestingly, both hiPSC-and miPSC-derived white matter-like astrocytes showed specific vulnerability to VWM mutations. RNAseq analysis on hiPSCderived astrocytes indicated differential gene expression in VWM compared to control astrocytes involved in several cellular mechanisms. Of these, genes involved in the immune system and extracellular matrix also selectively came up in miPSC-derived models, demonstrating the strength of cross-species validation in finding disease mechanisms induced by monogenic changes. Our results thereby provide new tools to generate astrocyte subtypes for the study of VWM and other astrocyte-associated diseases.
Materials and methods

HiPSC differentiation towards astrocytes
HiPSCs were differentiated towards human astrocytes (hAstro) as described previously ((Nadadhur et al., 2018) ; see also supplementary Materials and Methods). For CNTF-hAstro subtypes, instead of using commercially available Astrocyte Medium (Sanbio, ScienCell B.V.), medium was switched to N2B27-vitA medium supplemented with EGF (20 ng/ml), FGF2 (20 ng/ml) and CNTF (20 ng/ml, Peprotech), and cells were cultured for another 2 passages in 15 days. For FBS-hAstro, the medium was switched to N2B27-vitA medium supplemented with 10% FBS, and were cultured for 2 more passages in 15 days.
MiPSC differentiation towards mixed glial cells and astrocytes
MiPSCs obtained from wild-type (wt), Eif2b5 Arg191His/Arg191His (2b5 ho ) and
Eif2b4 Arg484Trp/Arg484Trp Eif2b5 Arg191His/Arg191His (2b4 ho 2b5 ho ) mice were initially differentiated towards glial progenitor cells. The mouse models and miPSC differentiation are described in Supplementary Materials and Methods.
For mixed glial differentiation, the glial progenitor cells were subsequently cultured in mouse neural maintenance medium supplemented with 30 ng/ml T3 and 10 ng/ml NT3 from day 12 on. At day 18 cells were used for analysis.
For astrocyte differentiation cells were cultured in mouse neural maintenance medium supplemented with 10% FBS or 10 ng/ml CNTF from day 12 onwards. To obtain purer astrocyte cultures, cells were passed every 7 days for an additional 2 passages. At day 32 cells were used for analysis.
Statistical analysis
For all experiments, results were considered significant at α = .05 after multiple test correction. RNA sequencing data was analyzed with R; all other data is analyzed with IBM SPSS statistics version 22 and Excel. Shapiro-Wilk test was used to confirm normal distribution of data and all data was tested with two-tailed tests. T-tests were used to compare FBS and CNTF astrocytes and VWM patients versus controls. To compare wild-type (wt), 2b5 ho and 2b4 ho 2b5 ho mouse data, one-way ANOVA with Dunnett post-hoc tests was used.
See supplementary materials and methods for more information.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Results
MiPSC-and hiPSC-based models recapitulate OPC maturation inhibition by VWM astrocytes
Previous studies showed that astrocytes isolated from VWM mouse models impair primary mouse OPC maturation via secreted factors, suggesting that astrocytes are the primary affected cell type in VWM (Dooves et al., 2016) . To show that iPSC-derived cell models recapitulate findings in primary cell models and to confirm that astrocytes cause cellular defects in VWM, we developed an in vitro miPSC model based on previous experiments with primary mouse cells. We generated miPSCs from wt, 2b5 ho and the severely affected 2b4 ho 2b5 ho mice (Fig. 2) . The miPSCs were differentiated towards glial cultures (mGlia) containing both astrocytes (~15 -25% GFAP + cells) ( Fig. 3A-C) and oligodendrocytes (~30 -40% Olig2 + cells) ( Fig. 3D-F, I) . Similar to previous primary mouse studies, oligodendrocyte maturation was significantly impaired in VWM mGlia, as was demonstrated by decreased numbers of MOG-expressing cells in both 2b5 ho and 2b4 ho 2b5 ho cultures ( Fig. 3H ; F(2, 5) = 7.83, p = .029, post-hoc Dunnett wt vs. 2b5 ho p = .047, wt vs. 2b4 ho 2b5 ho p = .047), and decreased numbers of MBP-expressing cells in 2b4 ho 2b5 ho cultures ( Fig. 3 D-G; F(2, 5) = 11.71 p = .013, post-hoc Dunnett wt vs. 2b4 ho 2b5 ho p = .02), while the percentage of Olig2-positive cells remained unchanged ( Fig. 3I) . To confirm that the decreased OPC maturation was caused by astrocytes, mGlia were co-cultured with primary wt mouse astrocytes. Indeed, wt mouse astrocytes rescued the oligodendrocyte maturation defect of the mGlia ( Fig. 3J-O) , demonstrating that miPSC models recapitulate cellular models using primary cells, and confirming previous findings that VWM astrocytes are responsible for OPC maturation defects.
To recapitulate findings with human iPSC models, we generated hiPSCs from VWM patients ( Fig. 4) (four iPSC lines from two patients, for extra information see supplementary M&M table 1) and healthy control donor fibroblasts (five hiPSC lines from three control donors; supplementary M&M table 1). To generate astrocytes, we differentiated control and VWM hiPSCs towards hiPSC-derived astrocytes (hAstro) as described earlier (Nadadhur et al., 2018) . We characterized the hAstro for expression of the astrocyte-associated markers GFAP, NESTIN, Id3, CD44 and SOX9 by immunocytochemistry ( Fig. 5A-F) , and NESTIN, BLBP, S100Β, ALDOC, AQP4, GLAST, GFAP and CD44 by RT-PCR ( Supplementary Fig.   1A ). Functionality of hAstro was demonstrated using calcium imaging, showing glutamate uptake in both control and VWM lines ( Supplementary Fig. 1B) . To confirm increased proliferation in VWM astrocytes as was described earlier for primary human astrocytes (Bugiani et al., 2011) , we performed a BrdU incorporation assay. The VWM hAstro showed a significant increase in the percentage of BrdU-positive cells compared to control hAstro ( Fig.   5G , H; independent t(6) = 2.56, p = .042). To show that hiPSC-derived astrocytes can mediate an oligodendrocyte maturation defect, primary mouse OPCs were cultured in astrocyte-conditioned medium (ACM) from control and patient hAstro ( Fig. 5I, J) . ACM from VWM hAstro significantly impaired OPC maturation, as measured by the percentage of MBP-positive of the total numbers OLIG2-positive cells ( Fig. 5I , J, K; independent t(3) = 2.34, p = .049). As hyaluronic acid (HA) has been previously described to inhibit OPC maturation (Back et al., 2005; Sloane et al., 2010) and is increased in brains of VWM patients (Bugiani et al., 2013) , ACM from hiPSC-based cultures was treated with hyaluronidase (HYAL). Addition of HYAL significantly increased OPC maturation in VWM ACM cultures (independent t(3) = -8.62, p = .002), recovering towards control levels ( Fig. 5K) . Altogether, our results demonstrate that hiPSC models recapitulate findings in both primary human cells and in miPSC cell models. Furthermore, we confirmed an astrocyte-intrinsic defect in VWM using hiPSC models.
MiPSCs differentiate into distinctive astrocytic subpopulations
An increasing number of studies confirm heterogeneity among astrocytes, such as white and grey matter-astrocytes, for which no specific iPSC-based differentiation protocols are available. CNTF-reactive astrocytes are predominantly found in the white matter (Dallner et al., 2002) , and FBS administration is standardly used to maintain cortical astrocytes (Goursaud et al., 2009) leading to a flat morphology that is common for grey matter astrocytes in culture. To generate white matter-or grey matter-like astrocytes, miPSCs were first differentiated to glial precursor cells that were subsequently cultured in media supplemented with CNTF or FBS respectively. The miPSC-derived astrocyte populations showed distinct morphological properties: where CNTF-induced astrocytes (CNTF-mAstro) formed a culture of cells with many thin protrusions ( Fig. 6A) , FBS-induced astrocytes (FBS-mAstro) formed a pure population of flat and round cells with less protrusions (Fig. 6B) .
These morphological differences were quantified using automated Columbus® software. The perimeter corrected for total surface area of the cell was larger in CNTF-mAstro ( Fig. 6C , t(12) = 3.52, p = .004), consistent with morphological observations of more and thinner protrusions. FBS-mAstro had a significantly larger surface area ( Fig. 6D , t(17) = -5.01, p < .001). While both cultures were highly GFAP-positive, the FBS-mAstro contained significantly more GFAP-positive cells ( Fig. 6E , 97% compared to 91% in CNTF-mAstro cultures; t(13) = -4.29, p < .001) and Nestin-positive cells ( Fig. 6F , 69% compared to 31% in CNTF-mAstro cultures; t(19) = -4.68; p < .001), showing a higher purity of FBS-induced cultures. The lower purity of CNTF-mAstro cultures was confirmed by higher levels of Olig2 mRNA ( Fig. 6G , t(12) = 2.59, p =.024). However, most astrocytic markers were higher expressed in CNTF-mAstro cultures on mRNA level, with significantly increased expression of Glast (Fig. 6G , t(14) = 5.39, p < .0001), S100β (Fig. 6G , t(16) = 2.30, p = .035), and Gfap ( Fig. 6G , t(17) = 2.52, p = .022). This is consistent with findings that show that white matter astrocytes have a higher expression level of these markers (Goursaud et al., 2009; Hassel et al., 2003; Steiner et al., 2007) . These results suggest that while both mAstro subtypes express high levels of astrocyte-associated markers and present with typical astrocyte-like morphologies, CNTF-mAstro are smaller and show increased expression of astrocyteassociated markers, in line with white matter astrocytes, whereas FBS-mAstro morphologically present as larger and rounder cells, in line with grey matter astrocytes (Lundgaard et al., 2014) .
MiPSC-based models show selective involvement of astrocytic subtypes in VWM
To assess functional defects of VWM CNTF-mAstro and FBS-mAstro, wt mouse primary OPCs were cultured in ACM collected from wt, 2b5 ho , and 2b4 ho 2b5 ho miPSCderived CNTF-mAstro or FBS-mAstro ( Fig. 6H-M) . While ACM from VWM FBS mAstro lines did not affect OPC maturation, the ACM from 2b4 ho 2b5 ho CNTF-mAstro significantly decreased the percentage of MBP-expressing cells compared to ACM from wt CNTF-mAstro ( Fig. 6N ; F(2, 8) = 6.22, p = .023, post-hoc Dunnett wt vs 2b4 ho 2b5 ho p = .007) and compared to ACM from 2b4 ho 2b5 ho FBS-mAstro ( Fig. 6N , t(6) = -5.657, p = .001). The percentage of Olig2-expressing cells was unchanged between conditions ( Fig. 6O) . Altogether, these findings demonstrate that CNTF-mAstro show a higher vulnerability to VWM mutations.
Since CNTF-mAstro are selectively affected by VWM mutations, we performed transcriptome analysis on wt and 2b4 ho 2b5 ho CNTF-mAstro to identify differentially expressed genes (DEGs) in the affected astrocytes. In total 13 genes were significantly differentially expressed between the wt and 2b4 ho 2b5 ho CNTF-mAstro ( Supplementary   Table 1 ), as labelled in Fig. 7A . Based on enrichment analysis for DEGs with GO terms ( Supplementary Table 1 ) and literature (Han et al., 2012; Dashzeveg et al., 2014; Das et al., 2015; Ishimoto et al., 2017) , DEGs were overrepresented in the categories 'Immune system', 'Development and proliferation', 'Extracellular matrix', 'RNA polymerase II transcription' and 'P53 mediated signaling' (Fig. 7B ), suggesting these processes are differentially regulated between VWM and wt CNTF-mAstro.
HiPSCs differentiate into distinctive astrocytic subpopulations
In order to show subtype specific abnormalities in human VWM cells, we generated CNTF-induced human astrocytes (CNTF-hAstro) and FBS-induced human astrocytes (FBS-hAstro) from control iPSC lines. Both subtypes showed immunostaining for astrocyteassociated markers GFAP, Nestin, and S100β ( Fig. 8A-F & Supplementary Fig. 1C-E) .
Similar to mAstro cultures, CNTF-hAstro cultures generated cells with many and thin protrusions ( Fig. 8A-C) , while FBS-hAstro cultures showed a more homogeneous population of flat and round astrocytes ( Fig. 8D-H) . Morphological analysis confirmed differences, although they did not reach statistical significance. FBS-hAstro were rounder ( Fig. 8G ; two sample t(4) = -1.385, p = .238), the surface of FBS-hAstro was larger ( Fig. 8H ; two samples t(4)= -1.813, p = .144), and the perimeter corrected for total surface area of the cell was higher in CNTF-hAstro compared to FBS-hAstro ( Fig. 8I ; two sample t(4) = 0.95, p = .40).
Expression of astrocyte-associated genes was studied by qPCR analysis and showed that all markers were higher expressed in CNTF-hAstro, reaching statistical significance for SOX9
(2.54 fold change, paired t(3) = -2.84, p = .026), Nestin (2.21 fold change, paired t(3) = -3.70, p = .034) and BLBP (14.07 fold change, paired t(3) = -4.1, p = .026) as compared to FBS-hAstro ( Fig. 8J) . To investigate whether the two hAstro subtypes could show a reactivity response, cultures were treated with polyinosinic:polycytidylic acid (Poly(I:C)), a synthetic dsRNA and ligand to TLR3-receptors (Marshall- Clarke et al., 2007) . mRNA expression levels of a number of genes involved in the astrocytic stress response (Clarke et al., 2018) were evaluated by qPCR. A comparison of the expression of these genes in the vehicle condition revealed no differences between subtypes and/or genotypes, except for FBLN5 ( Supplementary Fig. 1F , one-way ANOVA F(3,10) = 5.38, p = .02, post-hoc Dunnett Control CNTF-hAstro vs. Control FBS-hAstro p = .023, VWM CNTF-hAstro vs. Control FBS-hAstro p = .015). Both CNTF-hAstros and FBS-hAstros showed significant upregulation of TLR3 after Poly(I:C)-treatment as compared to cells in the H2O-treated control condition ( Fig. 8K ; CNTF-hAstros: paired t(3) = 3.62, p = .036; Fig. 8L , FBS-hAstros: paired t(3) = 5.01, p = .015). All reactivity-related genes that were tested to assess downstream stressrelated effects of TLR3 activation were expressed higher by Poly(I:C)-treated hAstro. After Poly(I:C) treatment, CNTF-hAstro showed a significant upregulation in FKBP5 (paired t(3) = 3.38, p = .043) and PTX3 (Fig. 8K; paired t(3) = 4.44, p = .021). FBS-hAstro showed a significant increase in FKBP5 (Fig. 8L; paired t(3) = 3.45, p = .041) and a trend in PTX3 (paired t(3) = 3.11, p = .053). Both CNTF-hAstro and FBS-hAstro showed a trend for upregulation of SERPING1 (paired t(3) = 2.96, p = .060 and paired t(3) = 2.92, p = .061, respectively). In short, both CNTF-and FBS-hAstro showed appropriate upregulation of reactivity-related genes in response to a cellular stressor, but no differences in reactive response between control CNTF-hAstro and FBS-hAstro were observed.
CNTF-hAstro and FBS-hAstro show distinctive gene expression profiles
As, to our knowledge, there are no transcriptome profiles of cultured, or purified, human grey and white matter astrocytes, we performed whole-genome transcriptome analysis on CNTF-hAstro and FBS-hAstro. Fig. 9A shows a volcano plot of DEGs in CNTF-hAstro compared to FBS-hAstro. In total, 346 genes were significantly differentially expressed between the subtypes (Supplementary Table 2) . Enrichment analysis with GO terms (Molecular functions) on the DEGs between CNTF-hAstro and FBS-hAstro could be classified in the categories 'Receptor/ligand activity', 'Extracellular space', 'Enzymatic activity', 'Immune system' and 'Cytoskeleton' (Fig. 9B) . These findings show that we generated two human astrocyte subpopulations in vitro: white matter-associated CNTF-hAstro and grey matter-associated FBS-hAstro, with specific morphological characteristics and differential expression profiles.
VWM mutations predominantly affect CNTF-hAstro over FBS-hAstro
To study astrocyte subtype abnormalities in VWM, we generated CNTF-hAstro and FBS-hAstro populations from control and VWM hiPSCs. To perform unbiased differential expression analysis, we performed transcriptome analysis of VWM and control CNTF-hAstro. In total, 63 genes were significantly differentially expressed between the VWM and control CNTF-hAstro (Supplementary Table 3) . A volcano plot of covariate-corrected DEGs in VWM compared control CNTF-is shown in Fig. 10A . When comparing control and VWM FBS-hAstro, 37 DEGs were detected (Supplementary Table 3) , which is almost half the number of DEGs found in the CNTF-hAstro subtype, suggesting the FBS-hAstro were less affected by VWM mutations. A volcano plot is presenting the covariate-corrected DEGs in VWM compared to control FBS-hAstro (Fig. 10B) . Enrichment analysis of GO terms (Biological processes) on the DEGs between control and VWM CNTF-hAstro could be categorized as 'Immune system', 'Extracellular space', 'Cell development', 'Neuronal functioning' and 'Vasculature-related', whereas the DEGs between control and VWM FBS-hAstro did not show significant enrichment in the latter two categories (Fig. 10C) . Full lists of all significant GO terms are available upon request. Since these results demonstrate that CNTF-hAstro presented a more broadly modulated transcript profile by a VWM genotype than FBS-hAstro, the differences between VWM and control CNTF-hAstro were further investigated. VWM compared to control CNTF-hAstro showed different morphologies (Fig.   10D, E) , although these did not reach statistical significance when quantified using automated Columbus® software. The VWM CNTF-hAstro were rounder ( Fig. 10F ; two sample t(4) = 0.62, p = .58), showed a larger surface area ( Fig. 10G ; two sample t(4) = 1.78, p = .15), and a reduced perimeter corrected for the surface area ( Fig. 10H; two sample t(4) = -1.00, p = .37) compared to control CNTF-hAstro. Furthermore, expression analysis for astrocyte-associated markers by qPCR analysis (Fig. 10I) showed that VWM CNTF-hAstro had a significantly higher expression of AQP4 (two sample t(5) = 2.94, p = .032) and NESTIN (two sample t(5) = 3.61, p = .015). These findings demonstrate that CNTF-hAstro were more profoundly affected by the VWM genotype than were FBS-hAstro.
Discussion
In this study we aimed to generate functional astrocytes and specify differentiation protocols for white and grey matter-like astrocyte subtypes from hiPSCs and miPSCs, using respectively CNTF or FBS supplementation. The astrocyte subtypes were characterized for astrocyte-associated markers, typical astrocyte-like morphologies, and reactivity in response to stress. VWM astrocytes showed intrinsic defects. In particular, the white matter-like astrocytes confirmed selective vulnerability for the VWM genotype. Most findings were validated across species, but certain pathways were specifically affected in VWM patient white matter-like astrocytes.
In vivo, astrocytes form a heterogeneous group of cells, with many subpopulations that vary in morphology, location and (Bayraktar et al., 2014; Molofsky and Deneen, 2015; Tabata, 2015) . Functionally grey and white matter astrocytes differ greatly, for example in glutamate uptake (Hassel et al., 2003; Goursaud et al., 2009) and gap junction coupling (Israel et al., 2003; Haas et al., 2006; Houades et al., 2006) . Therefore, we are in need of robust and efficient protocols that generate pure populations of human functional astrocyte subtypes. Even though hiPSC differentiation protocols have been developed to generate astrocytes with varying regional identities (Krencik and Zhang, 2011; Nadadhur et al., 2018) , so far no protocols to produce white and grey matter astrocytes are in place, which is complicated by the lack of grey and white matter-specific markers. However, increased expression of EGF, FGFR3, GFAP, Nestin, S100B, GLT1, GLAST and CNTF has previously been associated with white matter astrocytes (Pringle et al., 2003; Vinukonda et al., 2016 ) (Dallner et al., 2002; Hassel et al., 2003; Steiner et al., 2007; Goursaud et al., 2009) , as well as a smaller cell size and more complex processes in culture (Raff et al., 1983; Hughes et al., 1988; Landis et al., 1990; Bambrick et al., 1996; Haas et al., 2012) . Here we presented protocols for human and mouse grey and white matter-like astrocytes. Our CNTF-induced astrocytes were smaller, had more complex processes, and showed increased expression of astrocyte markers compared to FBS-induced astrocytes. This shows that these cells are consistent with white and grey matter astrocytes respectively and can be used for in vitro disease modeling (Li et al., 2018) and for therapy development (Zhang et al., 2016a) .
The studied markers are not specific for astrocyte subtypes. Increased expression of GFAP, BLBP, Nestin, SOX9 and S100β in astrocytes has been associated with a reactive or immature state (Clarke et al., 1994; Van Eldik and Wainwright, 2003; White et al., 2010; Sun et al., 2017) . Several studies suggest that CNTF induces activation of astrocytes (Clatterbuck et al., 1996; Wu et al., 2006; Seidel et al., 2015) , for example via the JAK/STAT pathway (Kahn et al., 1997) . However, under baseline conditions or after treatment with the cellular stressor Poly(I:C) the astrocyte subtypes did not show differences in expression levels of the reactivity-related genes, except for FBLN5. Upregulation of BLBP and Nestin in CNTFinduced astrocytes could indicate an immature phenotype (Zerlin et al., 1995; Anthony et al., 2004) . On the other hand S100β expression was also upregulated in CNTF-induced astrocytes and is thought to label a more mature population (Raponi et al., 2007) . Analysis of the RNAseq data showed increased LIFR (LIF receptor) transcript levels in our white matter-like astrocytes, which is associated with neural stem cell differentiation into GFAP-positive astrocytes (Koblar et al., 1998) , and a mature astrocyte state (Bennett et al., 2016; Zhang et al., 2016b; Clarke et al., 2018) . In accordance with this, CNTF-induced astrocytes showed upregulation of glutamate signalling-related DEGs GRIK3 and GRIA1, which indicates mature astrocyte functionality. These findings suggest that our CNTF-induced astrocytes do not represent an immature or a chronically reactive state.
Astrocytes play a central role in pathology in VWM (Bugiani et al., 2011; Leferink et al., 2017) . The presented astrocytes derived from miPSCs and hiPSCs recapitulate earlier findings in mouse and human, such as increased proliferation, morphological abnormalities and induction of decreased OPC maturation (Bugiani et al., 2011; Dooves et al., 2016) .
Interestingly, white matter-like astrocytes are more vulnerable to VWM mutations than grey matter-like astrocytes, as indicated before in patient tissue (Bugiani et al., 2011; Leferink et al., 2017) . Using mouse cultures we demonstrated that white matter-like astrocytes, but not grey matter-like astrocytes, inhibited OPC maturation. MiPSC-and hiPSC-based models represented species-specific features. Earlier studies indicated that HA is increased in brains of VWM patients (Bugiani et al., 2013) , but is not a clear determinant in disease phenotypes in primary cultures of VWM mouse cells (Dooves et al., 2016) . In contrast, but in line with findings in humans, impaired OPC maturation induced by human VWM astrocytes could be rescued by HYAL treatment. This suggests that iPSCs can be used to study intrinsic differences between astrocyte subtypes and to identify shared and unique disease mechanisms between species.
Transcriptome analyses on hiPSC and miPSC cultures both suggest involvement of immune system and extracellular matrix in VWM pathology. In mouse cultures only 13 DEGs between VWM and control were found, of which some genes have been related to VWM disease mechanisms before. Cd44 encodes a transmembrane receptor that regulates cellular responses to HA, was significantly upregulated in VWM compared to control mouse white matter-like astrocytes. Previous studies showed an increase in CD44 expression in VWM patient white matter astrocytes in post-mortem tissue (Bugiani et al., 2013) . Further, VWM mouse cultures showed increased Gli1 expression, which codes for a transcription factor that is a direct target of Sonic Hedgehog (SHH) signaling. SHH regulates proliferation of neural progenitor cells together with intracellular receptor Smoothened (SMO) and has neuroprotective effects (Patel et al., 2017) . While not significant, SHH and SMO levels were also decreased (2-2.5 fold) in VWM white matter-like astrocytes. A recent study showed an impaired SHH pathway in primary astrocytes from the Eif2b5 R132H/R132H mouse, confirming the involvement of the SHH pathway in VWM (Atzmon et al., 2018) . Interestingly, VWM mouse cultures also showed increased Ets1 expression. Ets1 is a transcription factor that is involved in the T-cell immune response and was shown to be upregulated in astrocytes surrounding white matter lesions in a mouse model for multiple sclerosis (Gerhauser et al., 2007) . These findings suggest that the SHH pathway and immune response are interesting targets for VWM.
Exclusively in the human white matter-like astrocytes, differences between VWM and control were associated with the GO terms 'Neuronal functioning' and 'Vasculature-related'.
The 'Neuronal functioning'-related DEGs include upregulation of GRID1, GRIA2, and GRIN2A in VWM which encode subunits of membrane ionotropic NMDA and AMPA receptors. A downstream effect of activation of these receptors is stimulation of the ATPdriven Na + pump. This induces glycolytic upregulation of ATP and lactate in astrocytes, as well as regulation of the extracellular potassium concentration because the ATP-driven Na + pump actively pumps potassium into the cells (Lanciotti et al., 2013) . The channel protein AQP4 is regulated by extracellular potassium levels and involved in water permeability of astrocytes (Nagelhus and Ottersen, 2013) , which can lead to neurotoxicity and myelin defects when dysregulated (Plog and Nedergaard, 2018) . Interestingly, VWM white matter-like astrocytes showed increased AQP4 levels. DEG analysis includes increased expression of SLC6A1, SLC6A11, and GABBR2 in VWM, which encode major transmembrane GABA transporter GAT-1, GAT-3, and GABAb receptor subunit 2, respectively. Increased extracellular levels of GABA, released by interneurons for example, lead to astrocytic Ca2 + elevations mediated by GABAb receptor activation (Guerra-Gomes et al., 2017) . This may further lead to astrocytic glutamate release, thereby potentiating inhibitory synaptic transmission (Kang et al., 1998) , and to astrocytic ATP/adenosine-mediated heterosynaptic suppression affecting excitatory transmission (Boddum et al., 2016) . So, the transcript analysis provided new insights into human specific signalling pathways possibly involved in VWM pathophysiology.
In conclusion, we have robustly created and characterized white and grey matter-like astrocyte subtypes using both mouse and human iPSCs. These specific subtypes are highly important to study diseases where specific astrocytes are affected, and for cellular replacement of those cells. By combining human and mouse models, we confirmed the selective and intrinsic vulnerability of white matter-like astrocytes for VWM mutations, and suggest involvement of the extracellular matrix and immune system in VWM disease mechanisms. The RNAseq profiles can serve as reference databases for validation and characterization of astrocyte subtype in both human and mouse. Future studies can benefit from new insights in VWM, and can apply developed protocols for the generation of subtype specific astrocytes in disease modeling and drug testing studies. Fibroblasts from human and mouse were reprogrammed to iPSCs (1) that were differentiated to grey matter-like and white matter-like astrocyte subtypes (2). To characterize these subtypes, morphology, protein and RNA expression profiles, and reactivity were assessed.
Figure legends
The various astrocyte subtypes were also used as an in vitro model for VWM (3), in which OPC maturation, morphology, proliferation rate, and protein and RNA expression was studied. Immunostaining for cytoplasmic cell surface marker Ezrin of CNTF-mAstro (A) and FBS-mAstro (B) showed morphological differences between the cells. Morphological analysis showed that CNTF-mAstro (n = 11) had a higher ratio of the perimeter corrected for the area (C) and had a smaller surface area (D) compared to FBS-mAstro (n = 10). Cell counts indicated that both populations contain > 90% of astrocytes, although the amount of GFAP + cells was significantly lower in CNTF-mAstro compared to FBS-mAstro (E). The percentage of Nestin-expressing cells was significantly decreased in CNTF-mAstro compared to FBS-mAstro (F). mRNA expression of Glt1, Glast, S100β, Nestin, Vimentin, Gfap and Olig2 was quantified in CNTF-mAstro and FBS-mAstro and is shown as mRNA fold change of CNTF-mAstro relative to FBS-mAstro (G). To assess functional defects of VWM CNTF-mAstro and FBS-mAstro, wt mouse primary OPCs were cultured in ACM collected from wt (n = 3), 2b5 ho (n = 4), and 2b4 ho 2b5 ho (n = 4) miPSC-derived CNTF-mAstro or FBS-mAstro (H-M). OPC maturation was quantified as the ratio of MBP + oligodendrocytes to the total amount of (DAPI + ) cells. This ratio was significantly decreased in 2b4 ho 2b5 ho CNTF-mAstro ACM Immunostaining showed expression of astrocyte markers GFAP (A&D), Nestin and S100B (B&E), and CD44 and SOX9 (C&F) in both control CNTF-hAstro (B-D) and FBS-hAstro (E-G). Scalebar = 100 µm. Morphological analysis showed differences in roundness (G), surface area (H), and perimeter corrected for area (I) between subpopulations of CNTF-hAstro (n = 7) and FBS-hAstro (n = 6) based on CD44 immunostaining. A qPCR on control CNTF-hAstro (n = 4) showed differential expression of SOX9, and BLBP relative to FBS-hAstro (n = 4). * = p < .05 (J). Treatment with Poly(I:C) elicited an upregulation of mRNA expression levels of all tested reactivity-associated genes as well as TLR3 in both CNTF-hAstro (n = 8; K) and FBS-hAstro (n = 8; L) as compared to the vehicle (dH2O)condition.
CNTF-hAstro showed a significant fold change increase of TLR3, FKBP5 and PTX3 mRNA.
FBS-hAstro showed a significant increase in TLR3 and FKBP5 mRNA. * = p <.05. Bars represent mean ± SEM. 
